Christine Cassiano
Chief Corporate Affairs and Brand Strategy Officer
Replay available
Allogene Therapeutics, Inc. (ALLO) Q2 2025 Earnings Call
Allogene Therapeutics, Inc. (NASDAQ: ALLO) Q2 2025 earnings conference call, held 2025-08-13. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. David Chang
President and Chief Executive Officer
Dr. Zachary Roberts
Executive Vice President of Research and Development and Chief Medical Officer
Jeff Parker
Chief Financial Officer
Tyler Van Buren
Analyst, TD Cowen
Byron Amin
Analyst, Piper Sandler
Salveen Richter
Analyst, Goldman Sachs
Kelly Shi
Analyst, Jefferies
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Allogene Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.816 Hello, and thank you for standing by, and welcome to Allogene Therapeutics' second quarter 00:00:04.816 -- 00:00:09.821 2025 conference call. After the speaker's presentation, there will be a question 00:00:09.821 -- 00:00:15.027 and answer session. To ask a question, please press star 1-1 on your telephone 00:00:15.027 -- 00:00:19.091 and wait for your name to be announced. To withdraw your question, please press star 00:00:19.091 -- 00:00:23.396 1-1 again. At this time, all participants are in a listen-only mode. 00:00:23.396 -- 00:00:26.459 Please be aware that today's conference call is being recorded. 00:00:26.459 -- 00:00:30.170 I would now like to turn the call over to Christine Cassiano. 00:00:30.170 -- 00:00:33.374 Chief Corporate Affairs and Brand Strategy Officer, Ms. 00:00:33.374 -- 00:00:36.515 Cassiano, please go ahead. 00:00:37.638 -- 00:00:40.561 Thank you, Operator, and thank you for joining this call. 00:00:40.561 -- 00:00:44.806 After the market closed, Allogene issued a press release that provided a business update 00:00:44.806 -- 00:00:47.249 and financial results for the second quarter of 2025. 00:00:47.249 -- 00:00:52.034 This press release and today's webcast are available on our website. 00:00:52.034 -- 00:00:54.976 Following our prepared remarks, we will host a Q&A session. 00:00:54.976 -- 00:00:58.840 We recognize that historically questions have been multifaceted, but note that we will 00:00:58.840 -- 00:01:00.682 endeavor to keep this call to under an hour. 00:01:00.682 -- 00:01:05.548 I'm joined today by Dr. David Chang, President and Chief Executive Officer, Dr. 00:01:05.548 -- 00:01:09.552 Zachary Roberts, Executive Vice President of Research and Development and Chief Medical 00:01:09.552 -- 00:01:12...